Histiocytosis

Explore clinical trials studying Histiocytosis. Study availability and eligibility vary by location and protocol.

17 public trials 6 recruiting studies

Refine in advanced search Browse all conditions

Histiocytosis trial results

Active, not recruiting

CD34+ (Non-Malignant) Stem Cell Selection for Patients Receiving Allogeneic Stem Cell Transplantation

NCT01966367

Conditions: Acquired Immunodeficiency Syndrome, Acquired Immunodeficiency Syndromes, Amegakaryocytic Thrombocytopenia, +65 more
Locations: Morgan Stanley Children's Hospital, New York-Presbyterian, Columbia University New York, United States

View Trial Details

Active, not recruiting

CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant

NCT02061800

Conditions: Acquired Immunodeficiency Syndrome, Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML), +74 more
Locations: Columbia University Irving Medical Center New York, United States

View Trial Details

Completed

Dabrafenib and Trametinib in People With BRAF V600E Mutation Positive Lesions in Erdheim Chester Disease

NCT02281760

Conditions: BRAF V600E Mutation, Hemic and Lymphatic Diseases, Histiocytosis, +2 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Treatment of Resistant Langerhans Cell Histiocytosis With ENBREL

NCT00048373

Conditions: Hemic and Lymphatic Diseases, Histiocytosis, Histiocytosis, Langerhans-Cell, +4 more
Locations: Texas Children's Hospital Houston, Texas, United States

View Trial Details

Completed

CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant

NCT01049854

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +28 more
Locations: New York Medical College Valhalla, New York, United States

View Trial Details

Completed

HLA-Nonidentical Stem Cell and Natural Killer Cell Transplantation for Children Less the Two Years of Age With Hematologic Malignancies

NCT00145626

Conditions: Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Anemia, +26 more
Locations: St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Completed

Ceftriaxone in Non-neutropenic Fever

NCT01225718

Conditions: Hemic and Lymphatic Diseases, Histiocytosis, Lymphatic Diseases, +1 more
Locations: Monroe Carrell Jr. Children's Hospital at Vanderbilt Nashville, Tennessee, United States

View Trial Details

Histiocytosis

Histiocytosis trial results

CD34+ (Non-Malignant) Stem Cell Selection for Patients Receiving Allogeneic Stem Cell Transplantation

CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant

Dabrafenib and Trametinib in People With BRAF V600E Mutation Positive Lesions in Erdheim Chester Disease

Treatment of Resistant Langerhans Cell Histiocytosis With ENBREL

CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant

HLA-Nonidentical Stem Cell and Natural Killer Cell Transplantation for Children Less the Two Years of Age With Hematologic Malignancies

Ceftriaxone in Non-neutropenic Fever

Related conditions